Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
May 5, 2025
Ensuring oxygen access is essential to achieving health for all
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Could new vaccines end malaria in Africa?
    After decades of research and development by PATH, GlaxoSmithKline, and other partners, the first doses of the RTS,S malaria vaccine began reaching children in Cameroon earlier this year.
    Published: February 2024
  2. Good intentions, bad outcomes: The dangers of donated medical devices
    COVID-19 spurred an increase in gifted medical devices, but the donations have left some facilities in under-resourced countries overwhelmed. PATH experts explain how too many facilities often lack training to use the equipment or funding to maintain it.
    Published: February 2024
  3. WHO grants prequalification to innovative polio vaccine, nOPV2, as nearly 1 billion doses are administered
    The World Health Organization granted prequalification to the novel oral polio vaccine type 2 (nOPV2), an innovative vaccine developed by a consortium of experts including PATH.
    Published: January 2024
  4. America’s Top 100 Charities
    PATH has again been named to Forbes’ annual list of the largest charities in the United States, based solely on private contributions. PATH scored 99 percent in fundraising efficiency and 89 percent in charitable commitment.
    Published: December 2023
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

964 Item s
964 Item s
    Date
    From
    To
  1. Join PATH at the African MedTech Conference 2025
    From August 27-29, 2025, PATH will join colleagues from Africa's medical technology community for the African MedTech Conference (TAMC 2025).
    Published: August 2025
    Announcement
  2. Unitaid announces two new flagship investments to boost regional manufacturing of diagnostics and medicines in Africa
    Unitaid is making a foundational investment of nearly US$ 50 million in two flagship programs aimed at strengthening the ability of countries in Africa to produce their own medical tests and treatments.
    Published: August 2025
    Announcement
  3. New study examines how generative AI can assist community health workers in Rwanda
    PATH and partners are conducting a research trial to assess how an AI knowledge assistant can help community health workers better triage and treat their patients.
    Published: July 2025
    Press Release
  4. PATH awarded Bristol Myers Squibb Foundation grant to tackle hemoglobinopathies in India
    New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of inherited blood disorders.
    Published: July 2025
    Announcement
  5. World Hepatitis Day: The partnership advancing hepatitis B care and prevention for mothers and newborns
    On World Hepatitis Day, a new initiative implemented by PATH and backed by Gavi, the Vaccine Alliance and Unitaid is taking aim at an urgent but overlooked threat to newborn health: hepatitis B.
    Published: July 2025
    Press Release
Next